Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hypersensitivity Reaction

Free Subscription 09.05.2022 7 Allergy 4 Am J Respir Crit Care Med 19 Ann Allergy Asthma Immunol 2 Br J Dermatol 2 Contact Dermatitis 3 Dermatology 3 Eur Respir J 8 Int Arch Allergy Immunol 1 J Allergy Clin Immunol 1 J Am Acad Dermatol 5 J Dermatol 1 J Pediatr 1 JAMA 1 Pediatr Dermatol 2 Pediatrics 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. VELASCO E, Delicado-Miralles M, Hellings PW, Gallar J, et al
   Epithelial and sensory mechanisms of nasal hyperreactivity.
   Allergy. 2022;77:1450-1463.
   PubMed         Abstract available
   
   
2. KIDOGUCHI M, Morii W, Noguchi E, Yuta A, et al
   HLA-DPB1*05:01 genotype is associated with poor response to sublingual immunotherapy for Japanese cedar pollinosis.
   Allergy. 2022;77:1633-1635.
   PubMed        
   
   
3. ZHANG W, Dhondalay GK, Liu TA, Kaushik A, et al
   Gastrointestinal gammadelta T cells reveal differentially expressed transcripts and enriched pathways during peanut oral immunotherapy.
   Allergy. 2022;77:1606-1610.
   PubMed        
   
   
4. SOUSA-PINTO B, Fonseca JA, Gemicioglu B, Regateiro FS, et al
   Patient-reported outcome measures (PROMs) using the MASK-air(R) app in severe asthma.
   Allergy. 2022 Feb 8. doi: 10.1111/all.15248.
   PubMed        
   
   
5. TURK M, Yilmaz I, Sahiner UM, Kocaturk E, et al
   Experience-based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance?
   Allergy. 2022;77:1626-1630.
   PubMed        
   
   
6. MITSELOU N, Andersson N, Bergstrom A, Kull I, et al
   Preterm birth reduces the risk of IgE sensitization up to early adulthood: A population-based birth cohort study.
   Allergy. 2022;77:1570-1582.
   PubMed         Abstract available
   
   
7. KLEUSKENS MTA, Haasnoot ML, Herpers BM, Ampting MTJV, et al
   Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function.
   Allergy. 2022;77:1510-1521.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

8. WEI Y, Qiu X, Sabath MB, Yazdi MD, et al
   Air Pollutants and Asthma Hospitalization in the Medicaid Population.
   Am J Respir Crit Care Med. 2022 Jan 24. doi: 10.1164/rccm.202107-1596.
   PubMed         Abstract available
   
   
9. TANG M, Elicker BM, Henry T, Gierada DS, et al
   Mucus Plugs Persist in Asthma and Changes in Mucus Plugs Associate with Changes in Airflow Over Time.
   Am J Respir Crit Care Med. 2022 Feb 1. doi: 10.1164/rccm.202110-2265.
   PubMed         Abstract available
   
   
10. SVENNINGSEN S, Nair P
    Persistent Airway Plugs: A Call for Clinical Recognition and Novel Therapies.
    Am J Respir Crit Care Med. 2022;205:977-978.
    PubMed        
    
    
11. MARKS GB
    Misuse of Pollution Reference Standards: No Safe Level of Air Pollution.
    Am J Respir Crit Care Med. 2022;205:984-985.
    PubMed        
    
    

    
    Ann Allergy Asthma Immunol

12. RIEDL MA, Johnston DT, Anderson J, Meadows JA, et al
    Optimization of care for patients with hereditary angioedema living in rural areas.
    Ann Allergy Asthma Immunol. 2022;128:526-533.
    PubMed         Abstract available
    
    
13. SPERGEL BL, Ruffner MA, Godwin BC, Liacouras CA, et al
    Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
    Ann Allergy Asthma Immunol. 2022;128:589-593.
    PubMed         Abstract available
    
    
14. STOUT S, Murphy H, Pandya A, Yeh HW, et al
    The Effect of COVID-19 on Asthma Visits.
    Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00048.
    PubMed        
    
    
15. GUILBERT TW, Biagini JM, Ramsey RR, Keidel K, et al
    Treatment by Biomarker-Informed Endotype Versus Guideline Care in Children with Difficult to Treat Asthma.
    Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00076.
    PubMed        
    
    
16. CHIPPS BE, Murphy KR, Wise RA, McCann WA, et al
    Assessing Construct Validity of the Asthma Impairment and Risk Questionnaire Using a 3-month Exacerbation Recall.
    Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00081.
    PubMed         Abstract available
    
    
17. ENG V, Moreno GP, Chang J, Liebhaber M, et al
    A Pediatric Asthma Camp Experience during the COVID-19 Pandemic.
    Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00087.
    PubMed        
    
    
18. GRAYSON MH
    New! American College of Allergy, Asthma and Immunology Annals fellow-in-training award program.
    Ann Allergy Asthma Immunol. 2022;128:483.
    PubMed        
    
    
19. BRAGANCA M, Placido JL, Amaral L
    Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments.
    Ann Allergy Asthma Immunol. 2022;128:595-597.
    PubMed        
    
    
20. RAMEY OL, Silva Almodovar A, Nahata MC
    Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00121.
    PubMed         Abstract available
    
    
21. D'NETTO M, Voelker D, Park M
    Pediatric penicillin skin testing with minor determinants and amoxicillin with or without oral drug challenge.
    Ann Allergy Asthma Immunol. 2022;128:609-610.
    PubMed        
    
    
22. LI L, Landon JE, Kim SC
    Trends in pharmacologic treatment of chronic idiopathic urticaria from 2016 to 2020.
    Ann Allergy Asthma Immunol. 2022;128:602-603.
    PubMed        
    
    
23. KOINIS-MITCHELL D, D'Angelo C, Dunsiger S, McQuaid E, et al
    Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00120.
    PubMed         Abstract available
    
    
24. LEUNG DYM
    Targeting the skin in atopic dermatitis.
    Ann Allergy Asthma Immunol. 2022;128:481-482.
    PubMed        
    
    
25. WHITE AA
    If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
    Ann Allergy Asthma Immunol. 2022;128:484-485.
    PubMed        
    
    
26. GALANT SP, Morphew T, Ehwerhemuepha L
    Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma.
    Ann Allergy Asthma Immunol. 2022;128:486-487.
    PubMed        
    
    
27. YAMANE M, Ohnishi H, Tsuji K, Anabuki K, et al
    Dupilumab-induced peripheral neuropathy in a patient with severe asthma.
    Ann Allergy Asthma Immunol. 2022;128:611.
    PubMed        
    
    
28. DAVIS EC, Jackson CM, Ting T, Harizaj A, et al
    Predictors and biomarkers of food allergy and sensitization in early childhood.
    Ann Allergy Asthma Immunol. 2022 Apr 28. pii: S1081-1206(22)00390.
    PubMed         Abstract available
    
    
29. CARDWELL FS, Elliott SJ, Chin R, St Pierre Y, et al
    Economic Burden of Food Allergy in Canada: Estimating Costs and Identifying Determinants.
    Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00393.
    PubMed         Abstract available
    
    
30. HASAN ARSHAD S
    Does allergen Immunotherapy for allergic rhinitis prevent asthma?
    Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00392.
    PubMed         Abstract available
    
    

    
    Br J Dermatol

31. GOLDENBERG M, Krishna SG, Milani-Nejad N, Trinidad JC, et al
    Response to: 'Validation of generalized drug-related rash diagnoses using International Classification of Diseases 9(th) and 10(th) Revision codes': reply from the authors.
    Br J Dermatol. 2022;186:911.
    PubMed        
    
    
32. CHEN CW, Wei JC
    Response to 'Validation of generalized drug-related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes'.
    Br J Dermatol. 2022;186:910-911.
    PubMed        
    
    

    
    Contact Dermatitis

33. OPPEL E, Hogg C, Oschmann A, Summer B, et al
    Contact allergy to the Dexcom G6 glucose monitoring system -role of 2,2'-methylenebis(6-tert-butyl-4-methylphenol) monoacrylate in the new adhesive.
    Contact Dermatitis. 2022 May 3. doi: 10.1111/cod.14141.
    PubMed         Abstract available
    
    
34. NAVARRO-TRIVINO FJ, Prados-Carmona A, Ruiz-Villaverde R
    Systemic allergic contact dermatitis caused by tea tree oil in a cream for treatment of molluscum contagiosum.
    Contact Dermatitis. 2022 May 3. doi: 10.1111/cod.14138.
    PubMed        
    
    

    
    Dermatology

35. COLLIER E, Sangar S, Shen A, Davis J, et al
    A Closer Look at Bleach Baths: Evidence, Tub Size, and Instructions.
    Dermatology. 2022;238:603-608.
    PubMed         Abstract available
    
    
36. BRONZ G, Rinoldi PO, Lavagno C, Bianchetti MG, et al
    Skin Eruptions in Acute Hemorrhagic Edema of Young Children: Systematic Review of the Literature.
    Dermatology. 2022;238:397-403.
    PubMed         Abstract available
    
    
37. ANDERSON J, Maghfour J, Hamp A, Christensen A, et al
    From the Cochrane Library: Emollients and Moisturizers for Eczema.
    Dermatology. 2022;238:594-596.
    PubMed        
    
    

    
    Eur Respir J

38. TAYTARD J, Koskas M, Beydon N
    Spirometry forced expiratory time is driven by airflow limitation in asthmatic children.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02620-2021.
    PubMed        
    
    
39. BUSBY J, Matthews JG, Chaudhuri R, Pavord ID, et al
    Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
    Eur Respir J. 2021 Sep 24. pii: 13993003.00768-2021.
    PubMed         Abstract available
    
    
40. SINGH D, Beier J, Astbury C, Belvisi MG, et al
    The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD.
    Eur Respir J. 2022;59.
    PubMed         Abstract available
    
    

    
    Int Arch Allergy Immunol

41. LUAN X, Cui C, Jiang J, Wang C, et al
    Salidroside Mitigates Airway Inflammation in Asthmatic Mice via the AMPK/Akt/GSK3beta Signaling Pathway.
    Int Arch Allergy Immunol. 2022;183:326-336.
    PubMed         Abstract available
    
    
42. KOYA T, Sakai N, Sasaki T, Shinbori K, et al
    Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population.
    Int Arch Allergy Immunol. 2021 Oct 15:1-9. doi: 10.1159/000519296.
    PubMed         Abstract available
    
    
43. REINSBERG M, Siebert S, Dreher C, Bogs T, et al
    Predictors of Airway Hyperresponsiveness in Symptomatic Children with Normal Spirometry and Suspicious of Possible Asthma.
    Int Arch Allergy Immunol. 2021 Dec 10:1-9. doi: 10.1159/000520670.
    PubMed         Abstract available
    
    
44. OZDEL OZTURK B, Yavuz Z, Eraslan D, Mungan D, et al
    Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.
    Int Arch Allergy Immunol. 2021 Dec 14:1-13. doi: 10.1159/000520725.
    PubMed         Abstract available
    
    
45. SOTO A, Perrone Sibilia M, Sanchez VR, Arcon N, et al
    Contribution of Kazal-Like Domains of the Serine Protease Inhibitor-1 from Toxoplasma gondii in Asthma Therapeutic Vaccination Effectiveness.
    Int Arch Allergy Immunol. 2022 Jan 11:1-8. doi: 10.1159/000520796.
    PubMed         Abstract available
    
    
46. FUKUMITSU K, Nishiyama H, Kanemitsu Y, Takeda N, et al
    Pretreatment Alveolar Nitric Oxide Levels Predict Improvement of Pulmonary Function 1 Year Following Anti-Asthma Treatments in Patients with Inhaled Corticosteroid-Naive Asthma.
    Int Arch Allergy Immunol. 2022 Jan 14:1-11. doi: 10.1159/000520508.
    PubMed         Abstract available
    
    
47. LIU Y, Zhang M, Zhang H, Qian X, et al
    Anthocyanins Inhibit Airway Inflammation by Downregulating the NF-kappaB Pathway via the miR-138-5p/SIRT1 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:539-551.
    PubMed         Abstract available
    
    
48. VALLE SOR, Alonso MLO, Dortas Junior SD, Goudouris ES, et al
    Acquired Angioedema due to C1-Inhibitor Deficiency: A Challenging Condition.
    Int Arch Allergy Immunol. 2022;183:572-577.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

49. TURNER PJ, Patel N, Rodriguez Del Rio P
    Clarifying the categorization of anaphylaxis as an adverse event during oral immunotherapy.
    J Allergy Clin Immunol. 2022 Apr 28. pii: S0091-6749(22)00443.
    PubMed        
    
    

    
    J Am Acad Dermatol

50. SILVERBERG JI, Rangel SM, Sheth A, Blumstein A, et al
    Single-question parent-reported global atopic dermatitis severity: a valid instrument in children.
    J Am Acad Dermatol. 2022 Apr 27. pii: S0190-9622(22)00706.
    PubMed        
    
    

    
    J Dermatol

51. BABA A, Kanekura T, Tsubouchi H
    Lichenoid drug eruption after coronavirus disease 2019 vaccination.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16294.
    PubMed        
    
    
52. NISHIOKA K, Koizumi A, Takita Y
    Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications.
    J Dermatol. 2022 Feb 16. doi: 10.1111/1346-8138.16325.
    PubMed         Abstract available
    
    
53. HASHIZUME H, Ajima S, Ishikawa Y
    Immunoglobulin A vasculitis post-severe acute respiratory syndrome coronavirus 2 vaccination and review of reported cases.
    J Dermatol. 2022;49:560-563.
    PubMed         Abstract available
    
    
54. TAKAMIYAGI S, Iriki H, Asahina Y, Furuichi Y, et al
    Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16415.
    PubMed         Abstract available
    
    
55. MATSUDATE Y
    Case of allergic contact dermatitis due to nickel contained in stainless steel skull pins.
    J Dermatol. 2022 May 3. doi: 10.1111/1346-8138.16421.
    PubMed        
    
    

    
    J Pediatr

56. BARBAROT S, Silverberg JI, Gadkari A, Simpson EL, et al
    The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study.
    J Pediatr. 2022 Apr 28. pii: S0022-3476(22)00342.
    PubMed         Abstract available
    
    

    
    JAMA

57. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
    PubMed        
    
    

    
    Pediatr Dermatol

58. THOMPSON AM, Seivright J, Hsiao JL, Shi VY, et al
    Bibliometric analysis of the 50 most cited publications in atopic dermatitis.
    Pediatr Dermatol. 2022 May 5. doi: 10.1111/pde.15027.
    PubMed         Abstract available
    
    

    
    Pediatrics

59. JAIN RP, Als D, Vaivada T, Bhutta ZA, et al
    Prevention and Management of High-Burden Noncommunicable Diseases in School-Age Children: A Systematic Review.
    Pediatrics. 2022;149.
    PubMed         Abstract available
    
    
60. CABANA MD, LeCroy MN, Menard-Livingston A, Rodgers CRR, et al
    Effect of Early Infant Probiotic Supplementation on Eczema, Asthma, and Rhinitis at 7 Years of Age.
    Pediatrics. 2022 Apr 14. pii: 186764. doi: 10.1542/peds.2021-052483.
    PubMed        
    
    

    
    PLoS One

61. CHAN AHY, Foot H, Pearce CJ, Horne R, et al
    Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0265715.
    PubMed         Abstract available
    
    
62. ISONO M, Kokado M, Kato K
    Why does it take so long for rare disease patients to get an accurate diagnosis?-A qualitative investigation of patient experiences of hereditary angioedema.
    PLoS One. 2022;17:e0265847.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: